s6y

Ocean Biomedical, Inc.

Ticker
OCEA
CIK
1869974
Industry
Pharmaceutical Preparations
Formerly
Ocean Biomedical, Inc./DE, Aesther Healthcare Acquisition Corp.

Financials 24

  1. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Jun 30, 2025
  2. 10-Q Quarterly Report for period ending Mar 31, 2025
  3. 10-K/A Annual Report for period ending Dec 31, 2024
  4. 10-K Annual Report for period ending Dec 31, 2024
  5. NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT for period ending Dec 31, 2024
  6. 10-Q Quarterly Report for period ending Sep 30, 2024
  7. 10-Q Quarterly Report for period ending Jun 30, 2024
  8. 10-Q Quarterly Report for period ending Mar 31, 2024
  9. 10-K Annual Report for period ending Dec 31, 2023
  10. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Mar 31, 2024

All 24 financials filings

News 80

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 80 news filings

Ownership 72

  1. SC 13G Major Shareholders
  2. SC 13G/A Major Shareholders
  3. SC 13G/A Major Shareholders
  4. SC 13G/A Major Shareholders
  5. SC 13G/A Major Shareholders
  6. SC 13G/A Major Shareholders
  7. SC 13G/A Major Shareholders
  8. SC 13G/A Major Shareholders
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 72 ownership filings

Prospectus 32

  1. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  2. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  3. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  4. S-1/A General form of registration statement for all companies including face-amount certificate companies
  5. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  6. S-1 General form of registration statement for all companies including face-amount certificate companies
  7. S-1/A General form of registration statement for all companies including face-amount certificate companies
  8. S-1/A General form of registration statement for all companies including face-amount certificate companies
  9. S-1 General form of registration statement for all companies including face-amount certificate companies
  10. 425 Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

All 32 prospectus filings

Proxies 15

  1. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  2. DEF 14A Definitive proxy statements
  3. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  4. DEF 14A Definitive proxy statements
  5. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  6. DEFR14A Definitive revised proxy soliciting materials
  7. DEF 14A Definitive proxy statements
  8. PRER14A Preliminary revised proxy soliciting materials
  9. PRER14A Preliminary revised proxy soliciting materials
  10. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition

All 15 proxies filings

Other 32

  1. 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
  2. SCHEDULE 13G/A
  3. EFFECT Notice of Effectiveness
  4. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  5. UPLOAD Letter (PDF)
  6. EFFECT Notice of Effectiveness
  7. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  8. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  9. D Exempt (Private) Offering
  10. UPLOAD Letter (PDF)

All 32 other filings